Elizabeth Lieschke
8PUBLICATIONS
76CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 30, 2025
Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformation.Erin M Lawrence, Amali Cooray, Andrew J Kueh
|Aug 19, 2024
Mouse models to investigate in situ cell fate decisions induced by p53.Elizabeth Lieschke, Annabella F Thomas, Andrew Kueh
|Dec 19, 2023
Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.Margs S Brennan, Kerstin Brinkmann, Gerard Romero Sola
|Oct 25, 2023
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells.Zilu Wang, Matteo Burigotto, Sabrina Ghetti
|Feb 24, 2023
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells.Zilu Wang, Huimin Hu, Luuk Heitink
|Feb 04, 2023
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells.Zilu Wang, Huimin Hu, Luuk Heitink
Pageof 2
Frequent Collaborators
6 joint publications
Andreas Strasser
5 joint publications
Gemma L Kelly
4 joint publications
Marco J Herold
4 joint publications
Connie S N Li-Wai-Suen
3 joint publications
Sarah T Diepstraten
3 joint publications
Lin Tai
2 joint publications
Diane Moujalled
2 joint publications
Allan Shuai Huang
2 joint publications
Kate Sutherland
2 joint publications
Kelly Rogers
